Despite being well characterized as suitable cell lines for antiviral drug screens with SARS-CoV-2, lung adenocarcinoma Calu-3 and colon adenocarcinoma Caco-2 cell lines both lack robust endogenous AR expression, rendering screening results uninterpretable for AR-targeting drugs. This evidence concerns the gene AR and lung adenocarcinoma.